iPSC-Derived Cell Therapies Summit

Temas de la conferencia
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies

The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/853667-3?pid=4832

Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more

https://go.evvnt.com/853667-1?pid=4832

Mr. Customer Services